Pro-angiogenic factors like VEGF-A and oncogenic drivers such as mutated KRAS within TDEs further stimulate vascular proliferation and remodeling, supporting tumor expansion and survival [174,175]. This evidence concerns the gene VEGFA and neoplasm.